Skip to content

KYMERA THERAPEUTICS, INC.

KYMR

CIK 0001815442

← back to feed
Revenue (TTM)
$70.71M
−16.7% YoY Q1 Apr 2026
Net Income (TTM)
−$293.6M
−39.1% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$3.42
−23.8% YoY Q1 Apr 2026
Gross Margin
0.0%
Q1 Apr 2026
Operating Margin
-474.7%
Q1 Apr 2026
Net Margin
-415.3%
Q1 Apr 2026
Free Cash Flow (TTM)
−$263.86M
Q1 Apr 2026
Cash
$144.09M
Q1 Apr 2026
Total Debt
—
Q1 Apr 2026
Shares Outstanding
82.26M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings